SNX LSE Week ended 07 Aug 2026

Weekly Investor Report

Synectics plc · Industrials · Security & Protection Services

Open interactive chart View report data
Latest close 185.0 GBP
0.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -7.4% below the Trend Line and sits at 19.1% of its 52-week range. The latest completed week returned 0.0%, after a -7.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 25 out of 100
Latest Close 185.0 GBP 7 Aug 2026
1W Return 0.0% latest completed week
4W Return -7.5% short-term follow-through
12W Return -9.8% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.0% Latest completed week; four-week move -7.5%. Indicator stack 0/42 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 37.26% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -7.4% below the Trend Line and sits at 19.1% of its 52-week range. The latest completed week returned 0.0%, after a -7.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2412-week average 0.20

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.5% over four weeks, -9.8% over 12 weeks, and -42.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.0%
4W-7.5%
12W-9.8%
26W-21.3%
52W-42.0%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.01Latest activity-pressure read.
Pressure change-100.8%Four-week change in activity pressure.
Leadership-27.96Latest relative-leadership reading.
RS change-19.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Nov 2025 Field coverage 91% Model confidence 68%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength85/100Blend of value, momentum, and quality. Underlying universe rank 16; rank 1 is best.
Value100/100Relative valuation strength. Underlying universe rank 1; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum2/100Medium-term price momentum. Underlying universe rank 99; rank 1 is best.
Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework99/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
8.5x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
2.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
36.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
42.8%
Gross profit retained from each unit of revenue.
Operating margin
8.8%
Operating profit retained from revenue.
Free-cash-flow margin
10.1%
Free cash flow generated from revenue.
Return on invested capital
14.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
22.0%
Latest one-year revenue growth.
EPS growth
14.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
4.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.5%
Cash dividends relative to market value.
Buyback yield
-0.5%
Net share repurchases relative to market value.
Shareholder yield
1.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

0 positive · 3 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.1%Distance below the 52-week high.
13-week volatility2.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 269 weeks finished lower.
Best week+12.9%Week of 27 Mar.
Worst week-23.3%Week of 6 Mar.
Latest week+0.0%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains5
Flat weeks8
Modest losses4
Sharp losses5
Recent vol2.1%13-week weekly-return volatility.
Base vol6.4%52-week weekly-return volatility.
Up/down split18/24Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis32/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.24; No reversal markers Next-Week ExpectancyNegative 37.26%

Next-week expectancy is negative with a 37.26% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors71/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 97; Buyback Yield rank 91; Small Cap Core rank 6 SVQF99/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 4.5 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

REG - Synectics PLC - EBT Share Purchase Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026185.0 GBP0.0%199.7 GBP230.1 GBP-0.01-27.96148.0KOff
31 Jul 2026185.0 GBP0.0%200.7 GBP229.6 GBP0.28-28.8057.5KOff
24 Jul 2026185.0 GBP-6.3%202.0 GBP229.1 GBP0.51-28.9376.9KOff
17 Jul 2026197.5 GBP-1.2%203.3 GBP228.7 GBP0.72-24.15117.9KOff
10 Jul 2026200.0 GBP0.0%204.4 GBP228.1 GBP0.74-23.44146.3KOff
3 Jul 2026200.0 GBP0.0%207.5 GBP227.5 GBP0.63-25.7928.1KOff
26 Jun 2026200.0 GBP0.0%210.3 GBP226.9 GBP0.56-25.6432.1KOff
19 Jun 2026200.0 GBP1.3%212.9 GBP226.3 GBP0.44-25.544.6KOff
12 Jun 2026197.5 GBP-1.2%215.0 GBP225.7 GBP0.37-28.1411.4KOff
5 Jun 2026200.0 GBP1.3%217.1 GBP225.2 GBP0.30-27.396.3KOff
29 May 2026197.5 GBP0.0%219.9 GBP224.6 GBP0.25-29.4671.5KOff
22 May 2026197.5 GBP-3.7%222.9 GBP224.0 GBP0.24-30.76292.0KOff
15 May 2026205.0 GBP1.2%225.8 GBP223.4 GBP0.19-27.0589.0KOff
8 May 2026202.5 GBP0.0%228.3 GBP222.8 GBP0.11-29.1236.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context